Ack1 Tyrosine Kinase Activation Correlates with Pancreatic Cancer Progression (2012)

Pancreatic cancer is a significant cause of cancer mortality worldwide as the disease has advanced significantly in patients before symptoms are evident. The signal transduction pathways that promote this rapid progression are not well understood. Ack1 or TNK2, an ubiquitously expressed oncogenic non–receptor tyrosine kinase, integrates signals from ligand-activated receptor tyrosine kinases to modulate intracellular signaling cascades. In the present study, we investigated the Ack1 activation profile in a pancreatic cancer tumor microarray, and observed that expression levels of activated Ack1 and pTyr284-Ack1 positively correlated with the severity of disease progression and inversely correlated with the survival of patients with pancreatic cancer. To explore the mechanisms by which Ack1 promotes tumor progression, we investigated the role of AKT/PKB, an oncogene and Ack1-interacting protein. Ack1 activates AKT directly in pancreatic and other cancer cell lines by phosphorylating AKT at Tyr176 to promote cell survival. In addition, the Ack1 inhibitor not Ack1 activation AKT tyrosine to cell in the in a significant in the of pancreatic cancer and of that activated Ack1 a or advanced pancreatic cancer. Ack1 to pancreatic tumor Pancreatic cancer is a significant cause of cancer mortality worldwide as the disease has advanced significantly in patients before symptoms are evident. The signal transduction pathways that promote this rapid progression are not well understood. Ack1 or TNK2, an ubiquitously expressed oncogenic non–receptor tyrosine kinase, integrates signals from ligand-activated receptor tyrosine kinases to modulate intracellular signaling cascades. In the present study, we investigated the Ack1 activation profile in a pancreatic cancer tumor microarray, and observed that expression levels of activated Ack1 and pTyr284-Ack1 positively correlated with the severity of disease progression and inversely correlated with the survival of patients with pancreatic cancer. To explore the mechanisms by which Ack1 promotes tumor progression, we investigated the role of AKT/PKB, an oncogene and Ack1-interacting protein. Ack1 activates AKT directly in pancreatic and other cancer cell lines by phosphorylating AKT at Tyr176 to promote cell survival. In addition, the Ack1 inhibitor not Ack1 activation AKT tyrosine to cell in the in a significant in the of pancreatic cancer and of that activated Ack1 a or advanced pancreatic cancer. Ack1 to pancreatic tumor Pancreatic cancer is the cause of in the survival patients with pancreatic cancer of the tumor from to Pancreatic to and are the of advanced are to survival kinases as a pancreatic advanced pancreatic the and pancreatic receptor pancreatic the of the inhibitor with a in the survival of with patients with with in patients with advanced pancreatic a of the of of not survival of tyrosine kinases and signaling is to the pathways that in pancreatic of receptor tyrosine signaling is kinase, which is the of and is activated in cancer of AKT kinases in The AKT in of to AKT has as a of tumor The AKT in at the and tumor AKT is activated in pancreatic which is correlated with and of activated AKT in of AKT by and by and is well of the pancreatic cell lines and activated AKT mechanisms of activation and expression in pancreatic cancer of the in patients with of the and the of tyrosine AKT activation in with and is activation in is not with of the of by tumor progression in of AKT and is Ack1 tyrosine as TNK2, is an ubiquitously expressed tyrosine that is activated by a of activated by and AKT and receptor by Ack1 tyrosine tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 promotes cancer progression receptor tyrosine of Ack1 tyrosine inhibitor receptor Ack1 activation in a of cancer by has the role of Ack1 signaling in pancreatic cancer has not Ack1 is at to AKT and receptor by Ack1 tyrosine tyrosine Ack1 promotes role of Ack1 in of tumor The Ack1 is in and which with and of the tyrosine of in Ack1 in and Ack1 tyrosine AKT and receptor by Ack1 tyrosine that Ack1 cancer progression to by the tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 promotes cancer progression receptor tyrosine of Ack1 tyrosine inhibitor receptor of the oncogene of Tyr176 in the AKT in by in a progression of the Ack1 tyrosine the present study, we that activated Ack1 expression by is significantly in pancreatic and in of advanced pancreatic cancer. AKT Tyr176 in pancreatic and is of the severity of the levels of activated Ack1 with survival which that signaling an role in progression of pancreatic cancer. the of the role of signaling the of pancreatic we of we pancreatic and of pTyr284-Ack1 and we and we of Ack1 inhibitor to we of and levels in pancreatic and other with and and and from the in and with and or and in and in with and or in with and or AKT and as of Ack1 tyrosine inhibitor receptor and from and Ack1 from the has Ack1 tyrosine and of AKT to the and the with and an to the of and of and by and The cell a pancreatic in the present study, which from patients to The and and pTyr284-Ack1 and The of pTyr284-Ack1 and of activated Ack1 and by in of and Ack1 tyrosine of Ack1 tyrosine inhibitor receptor The and the with pTyr284-Ack1 and at The with and The and with by The in a by and to the of and The of to to and The of the and as a to an pTyr284-Ack1 and as of pancreatic cancer of to the expression levels progression to the at the to in which of the expression levels and pTyr284-Ack1 and The of the expression levels of pTyr284-Ack1 and and the survival of patients the from a the of the advanced the survival pancreatic cancer with pTyr284-Ack1 and survival and with and survival the the with and and or with to and an as of Ack1 tyrosine inhibitor receptor cell the The cell the role of activated Ack1 in pancreatic tumor progression, we of pancreatic tumor is the in pTyr284-Ack1 to Ack1 we the of pTyr284-Ack1 and Ack1 tyrosine of pancreatic and The Ack1 levels and pancreatic and In to a significant in pTyr284-Ack1 expression in the of pancreatic and AKT expression in pancreatic with and to in the of the cancer is with the of AKT and role in of the cell at the and tumor and the with pTyr284-Ack1 and of the with and The expression levels of to and significant in expression of activated Ack1 from to to AKT Tyr176 an of progression of that expression levels of pTyr284-Ack1 and significantly of progression at The to and the expression levels of pTyr284-Ack1 significantly in the with the and levels of significantly in the with the at that patients with pancreatic cancer with pTyr284-Ack1 expression levels significantly survival with expression with and at survival the the the the with pTyr284-Ack1 and at significant observed expression levels and survival expression of pTyr284-Ack1 significantly correlated with in that in to Ack1 to promote expression correlated with survival in patients with pancreatic cancer. that patients with pancreatic cancer pTyr284-Ack1 expression levels and significantly survival with with expression levels in patients with pancreatic cancer that significant observed levels and survival of pTyr284-Ack1 significantly correlated with that of in pancreatic cancer of pancreatic a role of signaling in pancreatic cancer the and the that a inhibitor of pancreatic cancer cell a of as of of an and and as a Ack1 and has to cancer cell of Ack1 tyrosine inhibitor receptor the of by in the of of that Ack1 with an of not the other kinases and the AKT of the of we and in and To the of the with Ack1 or or Ack1 or Ack1 promotes cancer progression receptor tyrosine and AKT at to AKT at we of in and Ack1 tyrosine observed that and AKT in of Tyr176 to of AKT not at that the to integrates signals from a of and Ack1 tyrosine AKT and receptor by Ack1 tyrosine of pancreatic to of receptor and of Ack1 of Ack1 activation are with that Ack1 activated of AKT and receptor by Ack1 tyrosine and pancreatic of AKT and pTyr284-Ack1 and expression significantly in and and cancer with the Ack1 inhibitor Ack1 which to a in AKT and we that AKT in AKT as by AKT and Ack1 tyrosine observed that of Ack1 activation by not AKT AKT as by a significant in AKT and that not of Ack1 activation of pTyr284-Ack1 and expression in or with and with and and The by AKT or with and with and and and The by AKT and or with or and with and and The by AKT is Ack1 tyrosine which that the of to cell To Ack1 pancreatic cell with that significantly the of pancreatic To of cell an Pancreatic and and and cancer with of to pancreatic as and as significant in and cancer cell is with of to in cell observed in cancer cell and and at and significantly to with of to of pancreatic cancer or with and at significantly the of and or with to and an The with a is with and Ack1 and cell Ack1 and with Ack1 or and at with Ack1 or and a cell or with with and The and a is or with The cell and by a The of in and the is to inhibitor with Ack1 or by cell Ack1 a significant in cell as with and a cell In to Ack1 a significant in cell To this in cell to cell we cell or with and with In to the of in the of the cell by and in the by which that in cell in the a cell which of the to a of and the is from the and that at In to with significant in and that in the pancreatic cancer cell the oncogenic role of in and AKT and receptor by Ack1 tyrosine in of and Ack1 activation positively with cancer progression, and with Ack1 tyrosine of Ack1 tyrosine inhibitor receptor with to and of the of in cancer In the present study, we the that and pancreatic significantly levels of pTyr284-Ack1 or activated which with The activation of Ack1 in is the of signaling as is in that Ack1 activated by and In to other mechanisms of Ack1 activation in pancreatic cancer. Ack1 of Ack1 has in and and of the tyrosine Ack1 activated by from and of has a in and of Ack1 tyrosine in in pancreatic cancer is not are pancreatic tumor Ack1 and observed levels of pTyr284-Ack1 significantly levels of in is an as Ack1 is a pTyr284-Ack1 levels in of of AKT has not in which significantly levels of AKT is in pancreatic of and which are of the of in pancreatic Pancreatic and of kinases in kinases in cancer cell lines and tumor is not that of the pancreatic of that activates AKT and receptor by Ack1 tyrosine has significant expression of AKT in which the that the signaling in pancreatic activated Ack1 AKT in the of Ack1 tyrosine the present the of pathways in AKT activation in pancreatic and the of pancreatic to that in to Ack1 to promote survival. of the of Ack1 is tyrosine Ack1 promotes role of Ack1 in of tumor or the in a of and with and modulate that Ack1 at to and tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 pancreatic cancer progression by positively oncogenic AKT and the tumor to the of signaling we the a role the signaling in progression of pancreatic cancer. we that of this to of AKT with the Ack1 inhibitor not of cell lines from and the of of Ack1 signaling of pancreatic cancer. of this a in pancreatic cancer. Pancreatic cancer is the cause of in the survival patients with pancreatic cancer of the tumor from to Pancreatic to and are the of advanced are to survival kinases as a pancreatic advanced pancreatic the and pancreatic receptor pancreatic the of the inhibitor with a in the survival of with patients with with in patients with advanced pancreatic a of the of of not survival of tyrosine kinases and signaling is to the pathways that in pancreatic cancer. of receptor tyrosine signaling is kinase, which is the of and is activated in cancer of AKT kinases in The AKT in of to AKT has as a of tumor The AKT in at the and tumor AKT is activated in pancreatic which is correlated with and of activated AKT in of AKT by and by and is well of the pancreatic cell lines and activated AKT mechanisms of activation and expression in pancreatic cancer of the in patients with of the and the of tyrosine AKT activation in with and is activation in is not with of the of by tumor progression in of AKT and is Ack1 tyrosine as TNK2, is an ubiquitously expressed tyrosine that is activated by a of activated by and AKT and receptor by Ack1 tyrosine tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 promotes cancer progression receptor tyrosine of Ack1 tyrosine inhibitor receptor Ack1 activation in a of cancer by has the role of Ack1 signaling in pancreatic cancer has not Ack1 is at to AKT and receptor by Ack1 tyrosine tyrosine Ack1 promotes role of Ack1 in of tumor The Ack1 is in and which with and of the tyrosine of in Ack1 in and Ack1 tyrosine AKT and receptor by Ack1 tyrosine that Ack1 cancer progression to by the tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 promotes cancer progression receptor tyrosine of Ack1 tyrosine inhibitor receptor of the oncogene of Tyr176 in the AKT in by in a progression of the Ack1 tyrosine In the present study, we that activated Ack1 expression by is significantly in pancreatic and in of advanced pancreatic cancer. AKT Tyr176 in pancreatic and is of the severity of the levels of activated Ack1 with survival which that signaling an role in progression of pancreatic cancer. the of the role of signaling the of pancreatic we of we pancreatic and of pTyr284-Ack1 and we and we of Ack1 inhibitor to we of and levels in pancreatic and other with and and and from the in and with and or and in and in with and or in with and or AKT and as of Ack1 tyrosine inhibitor receptor and from and Ack1 from the has Ack1 tyrosine and of AKT to the and the with and an to the of and of and by and The cell a pancreatic in the present study, which from patients to The and and pTyr284-Ack1 and The of pTyr284-Ack1 and of activated Ack1 and by in of and Ack1 tyrosine of Ack1 tyrosine inhibitor receptor The and the with pTyr284-Ack1 and at The with and The and with by The in a by and to the of and The of to to and The of the and as a to an pTyr284-Ack1 and as of pancreatic cancer of to the expression levels progression to the at the to in which of the expression levels and pTyr284-Ack1 and The of the expression levels of pTyr284-Ack1 and and the survival of patients the from a the of the advanced the survival pancreatic cancer with pTyr284-Ack1 and survival and with and survival the the with and and or with to and an as of Ack1 tyrosine inhibitor receptor cell the The cell and and from the in and with and or and in and in with and or in with and or AKT and as of Ack1 tyrosine inhibitor receptor and from and Ack1 from the has Ack1 tyrosine and from the in and with and or and in and in with and or in with and or AKT and as of Ack1 tyrosine inhibitor receptor and from and Ack1 from the has Ack1 tyrosine and of AKT to the and the with and an to the of and of and by and The cell a AKT to the and the with and an to the of and of and by and The cell a pancreatic in the present study, which from patients to The and and pTyr284-Ack1 and The of pTyr284-Ack1 and of activated Ack1 and by in of and Ack1 tyrosine of Ack1 tyrosine inhibitor receptor The and the with pTyr284-Ack1 and at The with and The and with by The in a by and to the of and The of to to and The of the and as a pancreatic in the present study, which from patients to The and and pTyr284-Ack1 and The of pTyr284-Ack1 and of activated Ack1 and by in of and Ack1 tyrosine of Ack1 tyrosine inhibitor receptor The and the with pTyr284-Ack1 and at The with and The and with by The in a by and to the of and The of to to and The of the and as a to an pTyr284-Ack1 and as of pancreatic cancer of to the expression levels progression to the at the to in which of the expression levels and pTyr284-Ack1 and The of the expression levels of pTyr284-Ack1 and and the survival of patients the from a the of the advanced the survival pancreatic cancer with pTyr284-Ack1 and survival and with and survival the the with to an pTyr284-Ack1 and as of pancreatic cancer of to the expression levels progression to the at the to in which of the expression levels and pTyr284-Ack1 and The of the expression levels of pTyr284-Ack1 and and the survival of patients the from a the of the advanced the survival pancreatic cancer with pTyr284-Ack1 and survival and with and survival the the with and and or with to and an as of Ack1 tyrosine inhibitor receptor cell the The cell and or with to and an as of Ack1 tyrosine inhibitor receptor cell the The cell the role of activated Ack1 in pancreatic tumor progression, we of pancreatic tumor is the in pTyr284-Ack1 to Ack1 we the of pTyr284-Ack1 and Ack1 tyrosine of pancreatic and The Ack1 levels and pancreatic and In to a significant in pTyr284-Ack1 expression in the of pancreatic and AKT expression in pancreatic with and to in the of the cancer is with the of AKT and role in of the cell at the and tumor and the with pTyr284-Ack1 and of the with and The expression levels of to and significant in expression of activated Ack1 from to to AKT Tyr176 an of progression of that expression levels of pTyr284-Ack1 and significantly of progression at The to and the expression levels of pTyr284-Ack1 significantly in the with the and levels of significantly in the with the at that patients with pancreatic cancer with pTyr284-Ack1 expression levels significantly survival with expression with and at survival the the the the with pTyr284-Ack1 and at significant observed expression levels and survival expression of pTyr284-Ack1 significantly correlated with in that in to Ack1 to promote of pancreatic a role of signaling in pancreatic cancer the and the that a inhibitor of pancreatic cancer cell a of as of of an and and as a Ack1 and has to cancer cell of Ack1 tyrosine inhibitor receptor the of by in the of of that Ack1 with an of not the other kinases and the AKT of the of we and in and To the of the with Ack1 or or Ack1 or Ack1 promotes cancer progression receptor tyrosine and AKT at to AKT at we of in and Ack1 tyrosine observed that and AKT in of Tyr176 to of AKT not at that the to integrates signals from a of and Ack1 tyrosine AKT and receptor by Ack1 tyrosine of pancreatic to of receptor and of Ack1 of Ack1 activation are with that Ack1 activated of AKT and receptor by Ack1 tyrosine and pancreatic of AKT and pTyr284-Ack1 and expression significantly in and and cancer with the Ack1 inhibitor Ack1 which to a in AKT and we that AKT in AKT as by AKT and Ack1 tyrosine observed that of Ack1 activation by not AKT AKT as by a significant in AKT and that not of Ack1 activation of pTyr284-Ack1 and expression in or with and with and and The by AKT or with and with and and and The by AKT and or with or and with and and The by AKT is Ack1 tyrosine which that the of to cell To Ack1 pancreatic cell with that significantly the of pancreatic To of cell an Pancreatic and and and cancer with of to pancreatic as and as significant in and cancer cell is with of to in cell observed in cancer cell and and at and significantly to with of to of pancreatic cancer or with and at significantly the of and or with to and an The with a is with and Ack1 and cell Ack1 and with Ack1 or and at with Ack1 or and a cell or with with and The and a is or with The cell and by a The of in and the is to inhibitor with Ack1 or by cell Ack1 a significant in cell as with and a cell In to Ack1 a significant in cell To this in cell to cell we cell or with and with In to the of in the of the cell by and in the by which that in cell in the a cell which of the to a of and the is from the and that at In to with significant in and that in the pancreatic cancer cell To the role of activated Ack1 in pancreatic tumor progression, we of pancreatic tumor is the in pTyr284-Ack1 to Ack1 we the of pTyr284-Ack1 and Ack1 tyrosine of pancreatic and The Ack1 levels and pancreatic and In to a significant in pTyr284-Ack1 expression in the of pancreatic and AKT expression in pancreatic with and to in the of the cancer is with the of AKT and role in of the cell at the and tumor and the with pTyr284-Ack1 and of the with and The expression levels of to and significant in expression of activated Ack1 from to to AKT Tyr176 an of progression of that expression levels of pTyr284-Ack1 and significantly of progression at The to and the expression levels of pTyr284-Ack1 significantly in the with the and levels of significantly in the with the at that patients with pancreatic cancer with pTyr284-Ack1 expression levels significantly survival with expression with and at survival the the the the with pTyr284-Ack1 and at significant observed expression levels and survival expression of pTyr284-Ack1 significantly correlated with in that in to Ack1 to promote survival. of pancreatic a role of signaling in pancreatic cancer the and the that a inhibitor of pancreatic cancer cell a of as of of an and and as a Ack1 and has to cancer cell of Ack1 tyrosine inhibitor receptor the of by in the of of that Ack1 with an of not the other kinases and the AKT of the of we and in and To the of the with Ack1 or or Ack1 or Ack1 promotes cancer progression receptor tyrosine and AKT at to AKT at we of in and Ack1 tyrosine observed that and AKT in of Tyr176 to of AKT not at that the to Ack1 integrates signals from a of and Ack1 tyrosine AKT and receptor by Ack1 tyrosine of pancreatic to of receptor and of Ack1 of Ack1 activation are with that Ack1 activated of AKT and receptor by Ack1 tyrosine and pancreatic of AKT and pTyr284-Ack1 and expression significantly in and and cancer with the Ack1 inhibitor Ack1 which to a in AKT and we that AKT in AKT as by AKT and Ack1 tyrosine observed that of Ack1 activation by not AKT AKT as by a significant in AKT and that not of Ack1 activation of AKT is Ack1 tyrosine which that the of to cell To Ack1 pancreatic cell with that significantly the of pancreatic To of cell an Pancreatic and and and cancer with of to pancreatic as and as significant in and cancer cell is with of to in cell observed in cancer cell and and at and significantly to with of to to inhibitor with Ack1 or by cell Ack1 a significant in cell as with and a cell In to Ack1 a significant in cell To this in cell to cell we cell or with and with In to the of in the of the cell by and in the by which that in cell in the To a cell which of the to a of and the is from the and that at In to with significant in and that in the pancreatic cancer cell the oncogenic role of in and AKT and receptor by Ack1 tyrosine in of and Ack1 activation positively with cancer progression, and with Ack1 tyrosine of Ack1 tyrosine inhibitor receptor with to and of the of in cancer In the present study, we the that and pancreatic significantly levels of pTyr284-Ack1 or activated which with The activation of Ack1 in is the of signaling as is in that Ack1 activated by and In to other mechanisms of Ack1 activation in pancreatic cancer. Ack1 of Ack1 has in and and of the tyrosine Ack1 activated by from and of has a in and of Ack1 tyrosine in in pancreatic cancer is not are pancreatic tumor Ack1 and observed levels of pTyr284-Ack1 significantly levels of in is an as Ack1 is a pTyr284-Ack1 levels in of of AKT has not in which significantly levels of AKT is in pancreatic of and which are of the of in pancreatic Pancreatic and of kinases in kinases in cancer cell lines and tumor is not that of the pancreatic of that activates AKT and receptor by Ack1 tyrosine has significant expression of AKT in which the that the signaling in pancreatic activated Ack1 AKT in the of Ack1 tyrosine the present the of pathways in AKT activation in pancreatic and the of pancreatic to that in to Ack1 to promote survival. of the of Ack1 is tyrosine Ack1 promotes role of Ack1 in of tumor or the in a of and with and modulate that Ack1 at to and tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 pancreatic cancer progression by positively oncogenic AKT and the tumor to the of signaling we the a role the signaling in progression of pancreatic cancer. we that of this to of AKT with the Ack1 inhibitor not of cell lines from and the of of Ack1 signaling of pancreatic cancer. of this a in pancreatic cancer. the oncogenic role of in and AKT and receptor by Ack1 tyrosine in of and Ack1 activation positively with cancer progression, and with Ack1 tyrosine of Ack1 tyrosine inhibitor receptor with to and of the of in cancer In the present study, we the that and pancreatic significantly levels of pTyr284-Ack1 or activated which with The activation of Ack1 in is the of signaling as is in that Ack1 activated by and In to other mechanisms of Ack1 activation in pancreatic cancer. Ack1 of Ack1 has in and and of the tyrosine Ack1 activated by from and of has a in and of Ack1 tyrosine in in pancreatic cancer is not are pancreatic tumor Ack1 and observed levels of pTyr284-Ack1 significantly levels of in is an as Ack1 is a pTyr284-Ack1 levels in of of AKT has not in which significantly levels of AKT is in pancreatic of and which are of the of in pancreatic Pancreatic and of kinases in kinases in cancer cell lines and tumor is not that of the pancreatic of that activates AKT and receptor by Ack1 tyrosine has significant expression of AKT in which the that the signaling in pancreatic activated Ack1 AKT in the of Ack1 tyrosine the present the of pathways in AKT activation in pancreatic and the of pancreatic to that in to Ack1 to promote survival. of the of Ack1 is tyrosine Ack1 promotes role of Ack1 in of tumor or the in a of and with and modulate that Ack1 at to and tyrosine Ack1 promotes role of Ack1 in of tumor Ack1 pancreatic cancer progression by positively oncogenic AKT and the tumor to the of signaling In we the a role the signaling in progression of pancreatic cancer. we that of this to of AKT with the Ack1 inhibitor not of cell lines from and the of of Ack1 signaling of pancreatic cancer. of this a in pancreatic cancer. of the and and with and expression in pancreatic cancer. expression in pancreatic cancer to expression in pancreatic cancer to with of patients with pancreatic pTyr284-Ack1 expression levels with expression levels levels and survival with of Ack1 to with or and AKT and cell and Ack1 with Ack1 and AKT or cell by with The and Ack1 with and or with to to and an with a is with with with and expression in pancreatic cancer. expression in pancreatic cancer to expression in pancreatic cancer to with of patients with pancreatic pTyr284-Ack1 expression levels with expression levels levels and survival with of Ack1 to with or and AKT and cell and Ack1 with Ack1 and AKT or cell by with The and Ack1 with and or with to to and an with a is with with